loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 203883 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ADENOSINE (2)

filter

01 HOSPIRA (2)

filter

01 SOLUTION;INTRAVENOUS (2)

filter

01 60MG/20ML (3MG/ML) (1)

02 90MG/30ML (3MG/ML) (1)

filter

01 USA (2)

URL Supplier Web Content
SOLUTION;INTRAVENOUS
60MG/20ML (3MG/ML)
ADENOSINE
USA
203883
2014-03-24
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;INTRAVENOUS
90MG/30ML (3MG/ML)
ADENOSINE
USA
203883
2014-03-24
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203883

Looking for CTD TGA MCC DOSSIER APPLICATION 203883 2

19

Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is ADENOSINE, with a corresponding application number 203883 and regulatory information .

proudly manufactured in the

approval since 2014-03-24

Hospira, Inc.'s ADENOSINE SOLUTION;INTRAVENOUS, medication with 60MG/20ML (3MG/ML) of ADENOSINE.

18

Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is ADENOSINE, with a corresponding application number 203883 and regulatory information .

proudly manufactured in the

approval since 2014-03-24

Hospira, Inc.'s ADENOSINE SOLUTION;INTRAVENOUS, medication with 90MG/30ML (3MG/ML) of ADENOSINE.

Post Enquiry
POST ENQUIRY